Literature DB >> 31629732

Integrated metabolomics and network toxicology to reveal molecular mechanism of celastrol induced cardiotoxicity.

Chuanxin Liu1, Chenning Zhang1, Wenxin Wang1, Fuli Yuan1, Tao He1, Yahong Chen1, Qiang Wang1, Jianmei Huang2.   

Abstract

Celastrol (CS), an active triterpene derived from traditional Chinese medicine Tripterygium wilfordii Hook. f, has been used to treat chronic inflammation, arthritis and other diseases. However, it has been reported that CS can trigger cardiotoxicity and the molecular mechanism of heart injury induced by CS is not clear. Considering the wide application of Tripterygium wilfordii Hook. f in clinics, it is necessary to develop an accurate and reliable method to assess the safety of CS, and to elucidate as much as possible the mechanism of cardiotoxicity induced by CS. In this study, Ultra-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UPLC-Q-TOF/MS)-based metabolomics revealed clues to the mechanism of CS-induced heart injury. Palmitic acid significantly increased in plasma from CS-treated rats, and this increase resulted in oxidative stress response in vivo. Excessive ROS further activate TNF signaling pathway and caspase family, which were obtained from the KEGG enrichment analysis of network toxicology strategy. Protein expression level of caspase-3, caspase-8, bax were significantly increased by western blot. Q-PCR also showed the similar results as western blot. It means that apoptosis plays a key role in the process of celastrol induced cardiotoxicity. Blocking this signal axis may be a potential way to protect myocardial tissue.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiotoxicity; Celastrol; Metabolomics; Molecular mechanism; Network toxicology

Mesh:

Substances:

Year:  2019        PMID: 31629732     DOI: 10.1016/j.taap.2019.114785

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin.

Authors:  Na Hui Kim; Minji Kwon; Jiwoo Jung; Hyo Byeong Chae; Jiwoo Lee; Yeo-Jun Yoon; In Seok Moon; Ho K Lee; Wan Namkung; Konstantina M Stankovic; Se A Lee; Jong Dae Lee; Sin-Aye Park
Journal:  Acta Pharmacol Sin       Date:  2022-04-27       Impact factor: 6.150

2.  Elucidating the anti-aging mechanism of Si Jun Zi Tang by integrating network pharmacology and experimental validation in vivo.

Authors:  Yang Yuan; Yanghuan Zhang; Runzi Zheng; Hongjun Yuan; Ruoyu Zhou; Shuting Jia; Jing Liu
Journal:  Aging (Albany NY)       Date:  2022-05-10       Impact factor: 5.955

3.  Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.

Authors:  Dan Zhang; Yizhu Dong; Jintao Lv; Bing Zhang; Xiaomeng Zhang; Zhijian Lin
Journal:  BMC Complement Med Ther       Date:  2021-01-15

Review 4.  Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application.

Authors:  Jinfeng Shi; Jiaxin Li; Ziyi Xu; Liang Chen; Ruifeng Luo; Chen Zhang; Fei Gao; Jinming Zhang; Chaomei Fu
Journal:  Front Pharmacol       Date:  2020-11-18       Impact factor: 5.810

Review 5.  Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica-Induced Cardiotoxicity.

Authors:  Jie Zhou; Fu Peng; Xiaoyu Cao; Xiaofang Xie; Dayi Chen; Lian Yang; Chaolong Rao; Cheng Peng; Xiaoqi Pan
Journal:  Front Pharmacol       Date:  2021-03-30       Impact factor: 5.810

6.  SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer.

Authors:  Linxi Zhang; Xuefei Hu; Qingying Meng; Ye Li; Hao Shen; Yating Fu; Fan Zhang; Jiahui Chen; Wei Zhang; Wenjun Chang; Yamin Pan
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

Review 7.  Celastrol: A Promising Agent Fighting against Cardiovascular Diseases.

Authors:  Zhexi Li; Jingyi Zhang; Xulei Duan; Guoan Zhao; Min Zhang
Journal:  Antioxidants (Basel)       Date:  2022-08-18

Review 8.  Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications.

Authors:  Pushkaraj Rajendra Wagh; Preshita Desai; Sunil Prabhu; Jeffrey Wang
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

9.  Celastrol Prevents Oxidative Stress Effects on FSHR, PAPP, and CYP19A1 Gene Expression in Cultured Human Granulosa-Lutein Cells.

Authors:  Rita Martín-Ramírez; Rebeca González-Fernández; Deborah Rotoli; Jairo Hernández; Pablo Martín-Vasallo; Angela Palumbo; Julio Ávila
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.